SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-006350
Filing Date
2021-02-03
Accepted
2021-02-03 12:00:16
Documents
2
Period of Report
2021-02-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea134475-6k_chinasxt.htm 6-K 16795
2 EMPLOYMENT AGREEMENT ea134475ex10-1_chinasxt.htm EX-10.1 61549
  Complete submission text file 0001213900-21-006350.txt   79329
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 21585058
SIC: 2834 Pharmaceutical Preparations